Afatinib and Nivolumab as Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT03652233 · WITHDRAWN
Trial details
- NCT number
- NCT03652233
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-02
- Primary completion
- 2021-11-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.